| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Alexandria Forbes | PRESIDENT CEO | 2026-03-24 | 62,000 | $7.41 | $459.42kSell |
| Richard Giroux | CFO COO | 2026-02-21 | 31,726 | $7.45 | $236.36kSell |
| Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | 2026-02-21 | 5,949 | $7.45 | $44.32kSell |
| Stuart Naylor | CHIEF DEV. OFFICER | 2026-02-21 | 11,750 | $7.45 | $87.54kSell |
| Robert K. Zeldin | CHIEF MEDICAL OFFICER | 2026-02-21 | 2,952 | $7.45 | $21.99kSell |
| Alexandria Forbes | PRESIDENT CEO | 2026-02-21 | 33,048 | $7.45 | $246.21kSell |
| Richard Giroux | CFO COO | 2026-01-17 | 163,916 | $7.42 | $1.22MSell |
| Alexandria Forbes | PRESIDENT CEO | 2026-01-17 | 163,916 | $7.42 | $1.22MSell |
| Stuart Naylor | CHIEF DEV. OFFICER | 2026-01-17 | 35,250 | $7.42 | $261.56kSell |
| Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | 2026-01-17 | 27,206 | $7.42 | $201.87kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Sanofi | 14.98% | 12,197,737 | $111.98M | Insider |
| Sanofi | 14.98% | 12,197,737 | $111.98M | Institution |
| Perceptive Advisors LLC | 12.68% | 10,326,103 | $94.79M | Institution |
| Perceptive Advisors LLC | 12.56% | 10,231,103 | $93.92M | Insider |
| Johnson Innovatio Johnson | 8.15% | 6,641,064 | $60.96M | Insider |
| Johnson Johnson | 8.15% | 6,641,064 | $60.96M | Insider |
| Johnson Johnson | 8.15% | 6,641,064 | $60.96M | Institution |
| Rubric Capital Management LP | 7.58% | 6,175,331 | $56.69M | Institution |
| Perceptive Life Sciences Master Fund Ltd | 7.38% | 6,007,746 | $55.15M | Insider |
| Adage Capital Partners GP LLC | 4.91% | 4,000,000 | $36.72M | Institution |